Deflazacort
MP-104-CL-022OLE
Phase 3 small_molecule completed
Quick answer
Deflazacort for Duchenne Muscular Dystrophy is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Duchenne Muscular Dystrophy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed